Thomas Andersson Selected Research

3-amino-2-fluoropropylsulfinic acid

1/2007

Pharmaceutical and analytical characterisation of (2R)-(3-amino-2-fluoropropyl)sulphinic acid, a GABAB receptor agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Andersson Research Topics

Disease

3	Gastroesophageal Reflux (GERD) 05/2015 - 01/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Cognitive Dysfunction 01/2019 - 01/2018
2	Neoplasms (Cancer) 02/2015 - 01/2012
2	Pain (Aches) 02/2014 - 12/2004
1	Dementia (Dementias) 01/2022
1	Atrophy 01/2017
1	Flatulence 02/2015
1	Ileus 02/2015
1	Blister (Bulla) 01/2007
1	Hypohidrosis 12/2004
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 12/2004
1	Wounds and Injuries (Trauma) 02/2000

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	Butyric Acid (Butanoic Acid)IBA 05/2015 - 10/2013
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Pemetrexed (MTA)FDA Link 01/2017
1	AZD9343IBA 05/2015
1	Chewing Gum (Chewing Gums)IBA 02/2015
1	Analgesics (Analgesic Drugs)IBA 02/2014
1	Complement System Proteins (Complement)IBA 02/2014
1	lesogaberanIBA 10/2013
1	AcidsIBA 01/2007
1	3-amino-2-fluoropropylsulfinic acidIBA 01/2007
1	Dosage Forms (Dosage Form)IBA 01/2007
1	Nerve Growth Factor (NGF)IBA 12/2004

Therapy/Procedure

2	Pancreaticoduodenectomy 02/2015 - 01/2012
1	Length of Stay 02/2015
1	Analgesia 02/2014
1	Transcutaneous Electric Nerve Stimulation (TENS) 02/2014
1	Therapeutics 02/2014
1	Catheters 02/2000